Prevalence of dependence on prescription drugs and associated mental disorders in a representative sample of general hospital patients

General Hospital Psychiatry

Volumn 29, Issue 3, 2007, Pages 257-263

  Fach, Michèle ^a   Bischof, Gallus ^a   Schmidt, Christina ^a   Rumpf, Hans Juergen ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Dependence; General hospital; Pharmaceuticals; Prevalence

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE; CANNABIS; HYPNOTIC AGENT; SEDATIVE AGENT; TRANQUILIZER;

ADULT; ANXIETY DISORDER; ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; FEMALE; GENERAL HOSPITAL; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE;

ADOLESCENT; ADULT; DIAGNOSIS, DUAL (PSYCHIATRY); GERMANY; HUMANS; INPATIENTS; MENTAL DISORDERS; MIDDLE AGED; PRESCRIPTIONS, DRUG; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS;

EID: 34247620851     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2007.01.016     Document Type: Article

References (19)

1. Allgulander C., Ljungberg L., and Fisher L.D. Long-term prognosis in addiction on sedative and hypnotic drugs analyzed with the Cox regression model. Acta Psychiatr Scand 75 5 (1987) 521-531
2. Goodwin R.D., and Hasin D.S. Sedative use and misuse in the United States. Addiction 97 5 (2002) 555-562
3. Martinez-Cano H., De Iceta Ibanez de Gauna M., Vela-Bueno A., and Wittchen H. DSM-III-R co-morbidity in benzodiazepine dependence. Addiction 94 1 (1999) 97-107
4. Magrini N., Vaccheri A., Parma E., D'Alessandro R., Bottoni A., Occhionero M., and Montanaro N. Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol 50 (1996) 19-25
5. Graham K., and Vidal-Zeballos D. Analyses of use of tranquilizers and sleeping pills across five surveys of the same population (1985-1991): the relationship with gender, age and use of other substances. Soc Sci Med 46 3 (1998) 381-395
6. Hajak G., Müller W., Wittchen H., Pittrow D., and Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98 (2003) 1371-1378
7. Kan C., Hilberink S., and Breteler M. Determination of the main risk factors for benzodiazepine dependence using a multivariate and multidimensional approach. Compr Psychiatry 45 2 (2004) 88-94
8. Österling A., and Berglund M. Alcohol consumption and regular benzodiazepine use in 55-year-old female Malmö residents: results of a health screening. Acta Psychiatr Scand 94 (1996) 141-148
9. O'Brien C.P., and McLellan A.T. Myths about the treatment of addiction. Lancet 347 (1996) 237-240
10. Glaeske G. Psychotrope und andere Arzneimittel mit Missbrauchs- und Abhängigkeitspotential (Psychotropic and other pharmaceuticals with abuse- or dependence potential). Deutsche Hauptstell gegen die Suchtgefahren (German Council on Addiction Problems). Jahrbuch Sucht 2005 (2005), Neuland, Geesthacht 52-68
11. Augustin R., Semmler C., Rösner S., and Kraus L. Gebrauch und Missbrauch von Medikamenten. Ergebnisse des Epidemiologischen Suchtsurvey 2003 (Use and misuse of prescription medications. Results of the 2003 epidemiological survey of substance abuse). Sucht 51 1 (2005) 47-57
12. John U., Rumpf H.J., and Hapke U. Estimating prevalence of alcohol abuse and dependence in one general hospital - an approach to reduce sample selection bias. Alcohol Alcohol 34 (1999) 786-794
13. Kurz M. Early intervention strategies in substance abuse. Neural Transm 66 Suppl (2003) 85-96
14. de las Cuevas C., Sanz E.J., de la Fuente J.A., Padilla J., and Berenguer J.C. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 95 2 (2000) 245-250
15. Watzl H., Rist F., Höcker W., and Miehle K. Entwicklung eines Fragebogens zur Erfassung von Medikamentenmißbrauch bei Suchtpatienten (Development of a questionnaire for assessing abuse of prescription drugs in patients with addictive disorders). In: Heide M., and Lieb H. (Eds). Sucht und Psychosomatik: Beiträge des 3. Heidelberger Kongress (Addiction and psychosomatic: Contributions from the Third Heidelberg Congress) (1991), Nagel, Bonn 123-139
16. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., and Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90 5 (1995) 607-614
17. Wittchen H.-U., Wunderlich U., Gruschwitz S., and Zaudig M. SKID-I. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen (SCID-I. Structured Clinical Interview for DSM-IV, Axis I Disorders) (1997), Hogrefe, Göttingen
18. Spiegel D.A. Psychological strategies for discontinuing benzodiazepine treatment. J Clin Psychopharmacol 19 6 Suppl. 2 (1999) 17S-22S
19. Roche A., Freeman T., and Skiiner N. From data to evidence, to action: findings from a systematic review of hospital screening studies for high risk alcohol consumption. Drug Alcohol Depend 83 (2006) 1-14